US$ 28.32
new glp-1 agonists Trends in the Development of Receptor The Unstoppable Rise of GLP-1
Description
Eren S, Tonin G, Jurii Eren D, Klen J
20 118 [66.1%] female), with 14 101 undergoing MBS (mean [SD] follow-up, 34 [16] months) and 16 357 receiving GLP-1 RAs (mean [SD] follow-up, 32 [17] months)

Aspens Stavros Nicolaou said most countries outside the US, including South Africa, Mounjaro is marketed for both type 2 diabetes and weight loss
doi:10.1111/j.1463-1326.2012.01663.x 9

That ambiguity is precisely the problem
